BDC healthcare team launches $200M Amplitude Ventures Fund I
2019-11-06
BDC Capital, Fonds de solidarité, Teralys, IQ and CDPQ committed over $100M to BDC Capital healthcare investing spinout Amplitude Ventures Fund IRead More →
Metabolomic Technologies secures $4.2M Series A
2019-10-21
Metabolomic Technologies Inc., a developer of metabolomics-based in vitro diagnostics, secured $4.2 million in Series A financing from undisclosed investor(s)Read More →
Sofinnova Partners closes €333M 9th fund with €111M allocated for Canada and USA
2019-10-17
Sofinnova Partners closed early-stage healthcare fund Sofinnova Capital IX at €333M with 1/3 of the fund allocating to North American investments Read More →
AmacaThera completes US $3.6M seed financing led by Sprout BioVentures
2019-10-03
AmacaThera closed tranched US $3.6M seed financing with Sprout BioVentures/Viva Biotech, Grey Sky Venture Partners and Lumira Ventures.Read More →
OrbiMed and Power backed BELLUS closes US $70M offering and lists on NASDAQ
2019-09-09
Orbimed Advisors and Power Corporation backed BELLUS Health (NASDAQ/TSX: BLU) completed US $70M public offering in Canada and US and traded on NASDAQRead More →
MIMS secures $2.6M seed financing
2019-09-05
My Intelligences Machines (MIMS) secured $2.6M seed funding from members of Anges Québec, Anges Québec Capital, Desjardins Capital, Consortium MEDTEQ, Real Ventures, StandUp Ventures.Read More →
Repare Therapeutics secures US$82.5M Series B led by Cowen Healthcare Investments
2019-09-04
Repare Therapeutics secured US $82.5M Series B from Cowen Healthcare Investments, OrbiMed, Redmile, BVF Partners, Logos Capital, Versant Ventures, MPM Capital, Fonds de solidarité, BDC CapitalRead More →
OrbiMed and Power Corp backed BELLUS files for US $60M offering and NASDAQ listing
2019-09-03
OrbiMed, Power Corporation backed BELLUS Health filed for US $60M public offering and listing of its common shares on Nasdaq Global Market (NASDAQ) Read More →
ESSA Pharma closes US $36M public offering led by Soleus Capital
2019-08-27
ESSA Pharma closed US $36M public offering and private placement led by Soleus Capital with participation of RA Capital Management, BVF Partners, Omega Funds, Eventide Funds Read More →
Chinook Therapeutics closes US $65M Series A led by Versant Ventures
2019-08-22
Chinook Therapeutics secured US $65M Series A funding led by Versant Ventures with participation of seed investor Apple Tree Partners and new investor Samsara BioCapital.
Read More →
Zenabis Global secures $25M debt financing from R.C. Morris Capital
2019-08-21
R.C. Morris Capital Management Ltd. provided $25M senior secured debt to Zenabis Global Inc. (TSX: ZENA) Read More →
MolecuLight secures US $7.5M loan financing from Oxford Finance
2019-08-19
iGan Partners backed MolecuLight secured US $7.5M term loan from Oxford Finance LLCRead More →
